Protara Therapeutics
TARA
TARA
35 hedge funds and large institutions have $33.2M invested in Protara Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $47.1M → $33.2M (-$13.9M)
53% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 17
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
35
Holding in Top 10
1
Calls
$20K
Puts
$6K
Top Buyers
| 1 | +$224K | |
| 2 | +$123K | |
| 3 | +$87.8K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$53.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$15K |
Top Sellers
| 1 | -$598K | |
| 2 | -$537K | |
| 3 | -$519K | |
| 4 |
Goldman Sachs
New York
|
-$227K |
| 5 |
PA
Perceptive Advisors
New York
|
-$195K |